TRADING UPDATES: RWS launches AI offering; SulNOx patent wins
The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:
----------
RWS Holdings PLC - Maidenhead, England-based language services and artificial intelligence solutions provider - Launches Language Weaver Pro enterprise-grade artificial intelligence translation offering. It can deliver ‘accurate, contextually-fluent and secure translations at scale’, RWS says. ‘Ranking first in 31 of 32 languages in benchmarking tests, Language Weaver Pro outperformed leading AI translation tools - setting a new standard in AI translation,’ it adds. ‘Enterprises and governments have long faced an unacceptable reality: having to rely on consumer-grade AI translation that moves fast but falls short on accuracy, fluency and data security. Language Weaver Pro eliminates that shortfall.’
----------
SulNOx Group PLC - London-based green fuel technology developer - Gets three additional patents in Chile, Peru and Israel. They cover the firm’s Eco Fuel Conditioners offering which ‘enhance all diesel, petrol/gasoline and biofuels’ as well as marine fuels. ‘Sulnox has been granted more than 100 patents to date in major markets globally, protecting the company’s processes for emulsification and fuel oil reclamation, while supporting its revenue development,’ it adds. Chile is a ‘long-term’ opportunity for the company because of the mining sector, it says. Peru, meanwhile, ‘extends the mining opportunity’. ‘By contrast, Israel represents a strategically significant patent for Sulnox as the company expands across the Eastern Mediterranean and the Suez Canal corridor, supported by regional links to markets such as Jordan and Saudi Arabia where patents are also in place,’ SulNOx says.
----------
Medcaw Investments PLC - looks to identify and acquire prospective mining projects in the precious metals sector - Reports the Ontario Ministry of Energy & Mines grants early exploration permit for Eagle Lake gold asset. The permit is effective for three years. Medcaw adds: ‘The grant of the permit represents a material de-risking milestone for the project and enables the company to advance its planned exploration programme following completion of the proposed reverse takeover of 90% of Wedgetail Mining Ltd, which holds 100% of the project,’ Medcaw adds. Medcaw in December announced a plan to buy a majority stake in the gold asset.
----------
Gunsynd PLC - investor in the natural resource sector - Also notes early exploration permit PR-25-000274 granted by the Ontario Ministry of Energy & Mines and is effective for a period of three years. It authorises early exploration work at the Eagle Lake asset, which it has a legally binding term sheet to acquire a 10% interest in.
----------
Alien Metals Ltd - minerals exploration and development focused on Australia - Partner West Coast Silver Ltd reports that 4,000 metre reverse circulation drilling work has begun at Elizabeth Hill silver project in Western Australia. ‘The RC programme is designed to support expansion of the Elizabeth Hill mineralised footprint,’ West Coast Silver says.
----------
Agronomics Ltd - Isle of Man-based investor in cellular agriculture - Portfolio company, Clean Food Group Ltd launches its latest product, CLEANOil, before its debut at the in-cosmetics Global trade event in Paris between April 14 and 16. The offering ‘delivers the sensorial quality and functionality associated with premium oils - rich, silky, and naturally high in Omega 6 and 7’. The launch was achieved ‘through its collaboration with beauty manufacturer THG Labs’, part of THG PLC.
----------
Ethernity Networks Ltd - supplies of data processing semiconductor technology for networking appliances - Expects ‘enhancement-related revenue’ from a US customers in the range of $800,000 to $2.0 million for 2026. The development provides ‘increased visibility on near-term revenues’. ‘In addition, the Customer has commenced shipments of its platform incorporating Ethernity’s IP and is evaluating expansion to an additional platform. While discussions are ongoing, any additional licence agreement would represent incremental revenue beyond amounts set out above.’ Ethernity says.
----------
CRISM Therapeutics Corp - British Virgin Islands-based clinical-stage drug delivery company - US-based contract development and manufacturing organisation, ProMed Pharma LLC has manufactured the first clinical batch of ChemoSeed. ‘The batch will now undergo sterilisation and release testing, making it ready for use in the Phase 2 trial,’ CRISM adds. ‘The company also continues to work closely with its contract research organisation, Aixial, and the first clinical trial site, to complete the remaining site activation steps so as to commence patient dosing.’ Work towards dosing its ‘moving at pace’ but the exact timing is tough to anticipate, CRISM adds. ‘As such, the company is extending guidance on the timing of first patient dosing to H1 2026. The company remains focused on initiating the trial shortly and will provide further updates on the commencement of the trial as soon as possible,’ it adds. ChemoSeed looks to enable ‘sustained delivery’ of chemotherapies directly to cancer tissue.
----------
Copyright 2026 Alliance News Ltd. All Rights Reserved.